Is GSEU a good investment?

Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) is a Europe-focused ETF. As of September 11, 2026, ETF Copilot scores GSEU 6.1 out of 10 — highest on Valuation (7.6), lowest on Return (4.2). It trades at 16.5 times earnings, against its own median of 15.8. Its ten largest holdings are 18% of the fund.

Updated September 11, 2026

How is GSEU rated? ETF Copilot scores Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) 6.1 out of 10

As of September 11, 2026, ETF Copilot scores Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) 6.1 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

Overall: 6.1 / 10
Growth: 6.4 / 10
Valuation: 7.6 / 10
Risk: 7.3 / 10
Quality: 5.9 / 10
Return: 4.2 / 10

GSEU is ranked #10 of 10 in ETF Copilot's Rising Stars list.

What is GSEU's expense ratio? 0.25% a year

As of September 11, 2026, GSEU charges 0.25% a year, yields 3.32% and holds $175M in assets across 333 positions.

Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) — cost, income and size
Measure	GSEU
Expense ratio	0.25%
Dividend yield	3.32%
Assets under management	$175M
Holdings	333

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

What stands out in GSEU's data

European large- and mid-cap stocks, selected through a multi-factor model.

Earns more on its capital than the typical European fund — a sign of stronger business quality across its holdings.

Return on invested capital of 19.0% sits above the peer median of 16.8% and its own five-year median of 17.2%.

A value-conscious way to own broad European exposure without betting on a single factor.

Why did GSEU move this week? It fell 2.0% in the week to September 11, 2026 — Novartis and Novo Nordisk A/S-B drove it

GSEU fell 2.0% in the week to September 11, 2026. The holdings that moved it most were Novartis (−15.2%), Novo Nordisk A/S-B (−9.3%) and SAP (−4.6%); ASML (+3.8%) pushed the other way.

Is GSEU expensive right now? It trades at 16.5 times earnings, against its own median of 15.8

As of September 11, 2026, GSEU is more expensive than 58% of its own 114 monthly readings since 2017 — 66 of those months were cheaper than today.

Trailing twelve-month, computed by ETF Copilot from the fund's holdings rather than quoted from a data provider, and rebuilt nightly.

What's inside GSEU?

What's inside GSEU: Size (Large 57%, Mid 38%, Small 5%); Geography (International 92%, US 8%); Tech 9.5%; AI 0.8%; Semiconductors 5.2%; Memory 0.6%.

What are GSEU's top holdings? The ten largest are 18% of the fund

ASML, HSBC, Roche, Novartis, Shell, Banco Santander, AstraZeneca, Siemens, Allianz SE and Nestle are GSEU's largest holdings, in that order.

Less concentrated than 82% of Europe ETFs.

Half of GSEU's weight sits in its 61 largest positions, and once those weights are taken into account it behaves like 133 equally weighted holdings.

Cite this

ETF Copilot, “Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) scores and holdings analysis”, as of September 11, 2026.
https://etf-copilot.com/etf/gseu